Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-16 04:27:01 EDT

PhotosVideosAllPeople
LatestRanked
Load more
@diabetologiajnl.bsky.socialOct 16, 2026, 9:01 AM

CGM to track beta cell function in preclinical T1D: a novel digital biomarker to predict disease progression #T1D #CGM #DiabetesResearch link.springer.com/article/10.1... 🔓️

Photo, no description
@diabetictalks.bsky.socialOct 16, 2026, 12:45 AM

Diabetes is the 'uninvited guest' in every room and every conversation. Blog Intimacy, Experts & Underwear. wp.me/p6CU6c-4I #Diabetes #Relationships #T1D #Communication

Photo, no description
@thediabetespodcast.bsky.socialOct 15, 2026, 10:02 PM

Know a parent of a child with type 1? Share or repost this to help them feel less alone. Join our grassroots movement to spread hope and education in the fight against the type 2 and prediabetes epidemic. #diabetespodcast #T1D #DiabetesParents #Type1Diabetes

@thriveabetes.bsky.socialOct 15, 2026, 7:30 PM

Early diagnosis needs to be followed by timely, affordable care and ongoing support. And everyone living with diabetes deserves understanding and support, without stigma.

#ActEarlyOnDiabetes #WorldDiabetesDay #WDD2026 #Diabetes #Type1Diabetes #T1D #Type2Diabetes #T2D #LADA #MODY #T3c

Photo, no description
@ispadsociety.bsky.socialOct 15, 2026, 12:02 PM

🌎 A New World of Screening: Expanding Prevention Beyond Traditional Research

What’s next for #T1D screening, risk assessment, and prevention? Join three experts at #ISPAD 2026 in Rio to explore more.

Still need to register? https://loom.ly/xkAylRs

See you in Rio! 🌎

#ISPAD #ISPAD2026

@nancyquinn.bsky.socialOct 15, 2026, 11:52 AM

And did you know he has #T1D?

#GOBREWERS ⚾️

@ispadsociety.bsky.socialOct 15, 2026, 9:00 AM

Join us TODAY for our ISPAD webinar at 7:00 AM PST for: "The Race to Faster Insulin: Innovation in Formulation"

👉 More info and registration here: https://loom.ly/CkOgdKA

#ISPAD #DiabetesEducation #T1D #PediatricDiabetes #ISPADWebinar

Photo, no description
@thelancetendo.bsky.socialOct 15, 2026, 7:52 AM

#Cancer and #diabetes have common risk factors, with #overweight and #obesity being major underlying contributors to both conditions. In addition, cancer and diabetes are closely intertwined and show a bidirectional relationship www.thelancet.com/journals/lan...
#T1D #T2D

#MedSky #EndoSky #OncSky

Photo, no description
@diabetictalks.bsky.socialOct 15, 2026, 12:45 AM

Persistence is more valuable than perfection in diabetes care. Read 'What is Real VI' for an honest discussion about diabetes and erectile dysfunction. wp.me/p6CU6c-P #Diabetes #T1D #T2D #DiabetesAwareness

Photo, no description
@play.breakthrought1d.orgOct 14, 2026, 8:47 PM

Do you livestream on Twitch and want to help the 9.5 million people living with #type1diabetes? 👀💫

🎮 Are you a gamer looking to connect with others gamers living with #T1D or with a T1D connection? 🎮

Join the Breakthrough T1D Play Discord today! 🤗 discord.gg/mmQdzcUrNx

@apsphysiology.bsky.socialOct 14, 2026, 7:00 PM

People with Type 1 #diabetes often heal more slowly. Could molecules already in your body help improve wound healing? Learn more in a researcher Q&A this week on the #ISpyPhysiology blog: https://ow.ly/Q2kw50ZXLex #Comparative2026 #T1D 🧪

@nancyfreund.bsky.socialOct 14, 2026, 3:34 PM

I watch Dr. Brook Goldner's live q&a hour every Wednesday because she's so uplifting. Her protocols have made a BIG difference in my health. Just FYI. Free. #T1D, #chronicillness #autoimmune www.youtube.com/watch?v=tz0c...

@adapubs.bsky.socialOct 14, 2026, 3:15 PM

SGLT inhibitors have the potential to transform heart and kidney outcomes in #T1D. Here’s the roadmap to make it happen.

Read here ➡️ doi.org/10.2337/dc26-0999

This image is an infographic titled "Perspective: SGLT1 for Heart and Kidney Disease in T1D." It is divided into three main sections: 1. "Perspective on benefits" discussing therapeutic mechanisms, intermediate cardiovascular outcomes, and SGLT1 efficacy. 2. "Perspective on risks" highlighting DKA as the major risk, the need for education on ketone monitoring, and the importance of clinical trials. 3. "Conclusions" summarizing the balance of potential benefits and risks, including insights on pivotal trials and the importance of stakeholder discussions. Key terms include DKA, SGLT1, SGLT2, and T1D.
@easdnews.bsky.socialOct 14, 2026, 12:00 PM

⭐️ #DiabetesDistress affects almost 1/2 of all adults living with #T1D, but it is rarely addressed systematically. A new review explores how structured assessment plus meaningful questions could help address emotional well-being in routine #DiabetesCare.

Read here: easd-elearning.eu/news/481/Int...

Photo, no description
@diabetictalks.bsky.socialOct 14, 2026, 12:45 AM

Living well means understanding your behaviors. Dive into the fascinating psychology behind our food choices with 'Eat Free & Die Hard'. wp.me/p6CU6c-4O #Diabetes #T1D #T2D #DiabetesAwareness

Photo, no description
@joshualevy.bsky.socialOct 13, 2026, 11:54 PM

This is a sad blog posting. I'm reporting on three different clinical trials which were terminated while running:
cureresearch4type1diabetes.blogspot.com/2026/10/thre...
#T1D #type1diabetes #siplizumab

@thriveabetes.bsky.socialOct 13, 2026, 6:30 PM

Imperfect Days is coming to RTÉ One. 📺
This powerful Irish documentary explores diabetes, sharing personal experiences alongside the work being done to better understand diabetes.

📅 Mon, 19 Oct
🕣 8:30pm
📺 RTÉ 1

💙 Please share and help us spread the word.

#IREDOC #NIDOC #SpeirGorm #T1D #T2D

@adapubs.bsky.socialOct 13, 2026, 12:55 PM

In adults with #T1D, 3-year CGM data showed distinct glycemic trajectories across high-risk subgroups, with substantial within-group variability—risk labels alone are insufficient.

Read here ➡️ doi.org/10.2337/dc26-1039

Chart titled "Three-year CGM trajectories highlight clinically relevant subgroup patterns in type 1 diabetes" displays data in three panels: Older age (≥65 years), CKD (eGFR <60 mL/min/1.73 m²), and β-cell failure (C-peptide <200 pmol/L). Each panel shows graphs of %TIR 70-180 mg/dL and %TBR <70 mg/dL over 36 months, with high-risk (orange) and reference groups (blue). Clinical implications summarized below each panel.
@ispadsociety.bsky.socialOct 13, 2026, 12:02 PM

Join the next ISPAD webinar is in only 2 days on 15 October at 7:00 AM PST for: "The Race to Faster Insulin: Innovation in Formulation"

👉 More info and registration here: https://loom.ly/CkOgdKA

#ISPAD #DiabetesEducation #T1D #PediatricDiabetes #ISPADWebinar

Photo, no description
@diabetictalks.bsky.socialOct 13, 2026, 12:45 AM

Managing a chronic illness is a true team effort for couples. Explore the harsh reality of relationships and high blood sugars in 'What is real III'. wp.me/p6CU6c-E #Diabetes #Relationships #T1D #Communication

Photo, no description